Drugs / ZYC300
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00381173 | Nov 2006 → Oct 2008 | breast cancer, colorectal cancer, kidney cancer, ovarian cancer +1 | Eisai Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ZYC300 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00381173 ↗ |